With 75% of deaths related to NCDs and mental health conditions in low- and middle-income countries – accounting for 32 million lives lost each year – affordable access to key medical tools should be a necessity, not a luxury Geneva/New York, 16 December 2025 – Yesterday, nearly three months after it was first considered at … Read more
In the Central African Republic, living with diabetes is a real challenge. Access to treatment is limited, medicines such as insulin are expensive and often difficult to find, and structured patient care programmes are rare. In Carnot, in the southwest of the country, Médecins Sans Frontières (MSF), in collaboration with the Ministry of Health and … Read more
Cox’s Bazar, Bangladesh – 22 May 2025 – To address concerningly high levels of hepatitis C in the Rohingya refugee camps in Cox’s Bazar, Bangladesh, 30,000 people will receive care by the end of 2026 as Médecins Sans Frontières (MSF) significantly expands its treatment programmes. The initiative improves access to hepatitis C care for a … Read more
Diabetes ranks among the top 10 causes of death globally and affects over half a billion people worldwide. Over 80% of those affected live in low- and middle-income countries (LMICs). Insulin pens and newer diabetes medicines can simplify treatment and reduce complications for people with diabetes. While these tools are widely available in high-income countries, … Read more
Activists present ‘Time for $5’ petition signed by over 206,000 people asking US corporations Cepheid and Danaher to drop test prices Bali/Geneva, 12 November 2024 – At the annual TB Union Conference, taking place in Bali, Indonesia, over 70 TB activists, including Doctors Without Borders/Medecins Sans Frontieres (MSF), took the stage during the opening ceremony to … Read more
80% of people with diabetes live in low- and middle-income countries, where access to insulin pens is extremely limited due primarily to high prices. Geneva/Johannesburg, 11 November 2024 – Ahead of World Diabetes Day, Médecins Sans Frontières/Doctors Without Borders (MSF) called on pharmaceutical corporations Eli Lilly, Novo Nordisk, Sanofi, and all insulin manufacturers to take urgent action … Read more
Bihar, India– Since 2019, Médecins Sans Frontières (MSF) has been actively working in Bihar to provide crucial support to individuals living with advanced HIV at Guru Gobind Singh Hospital in Patna. This vulnerable population confronts numerous critical challenges, including: Limited access to essential medications Parent-to-child transmission Difficulties in accessing tertiary healthcare Discrimination in healthcare settings … Read more
Gilead’s Price is 1,000 Times the Target Generic Price for 100% Effective Prevention Shot Munich, 23 July 2024: Today at the International AIDS Conference, a coalition of activists, including Médecins Sans Frontières (MSF), called for immediate global action to break Gilead’s monopoly on lenacapavir, in response to new data showing that generic lenacapavir can be … Read more
Mumbai, 17 July 2024 – On Friday 5 July 2024, the “pre-grant opposition” filed in December 2020 by The Delhi Network of Positive People (DNP+) and a Mumbai-based tuberculosis (TB) survivor Ganesh Acharya, and supported by Médecins Sans Frontières/Doctors Without Borders (MSF) was successful: the Indian Patent Office rejected the US pharmaceutical corporation Johnson & … Read more
The patent withdrawal is a result of an unprecedented investigation by South Africa’s Competition Commission into J&J We welcome today’s news that following the Competition Commission’s investigation initiation into anti-competitive practice, J&J has officially withdrawn its secondary patents in South Africa on the lifesaving TB drug bedaquiline, opening up generic competition in South Africa. Candice … Read more